Biogen
BIIB
BIIB
1,034 hedge funds and large institutions have $34.8B invested in Biogen in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 349 increasing their positions, 396 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
27% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.7B
42% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 124
44% less funds holding in top 10
Funds holding in top 10: 27 → 15 (-12)
Holders
1,034
Holding in Top 10
15
Calls
$1.24B
Puts
$1.7B
Top Buyers
| 1 | +$195M | |
| 2 | +$118M | |
| 3 | +$113M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$70.9M |
| 5 |
Amundi
Paris,
France
|
+$66.6M |
Top Sellers
| 1 | -$181M | |
| 2 | -$117M | |
| 3 | -$115M | |
| 4 |
Renaissance Technologies
New York
|
-$98.6M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$87.3M |